We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SARTORIUS AG

Sartorius AG is a developer of bioprocess solutions and laboratory products and services that enable pharmaceutical r... read more Featured Products: More products

Download Mobile App




New Bioreactor System Streamlines Strain Screening and Culture

By LabMedica International staff writers
Posted on 23 Nov 2015
Biotechnology laboratories working with bacterial cultures will benefit from a new automated micro bioreactor system that was designed to enhance microbial strain screening processes.

The Sartorius Stedim Biotech (Aubagne, France) new ambr 15 fermentation system comprises 24 single-use stirred micro-bioreactors (each with an 8 to 12 milliliter working volume) integrated with a user-friendly, automated workstation. More...


The system, which is based on Sartorius' gold-standard ambr 15 micro-bioreactor technology, offers parallel processing and walk-away control of 24 micro-bioreactors. These features provide the researcher with efficient, consistent results from an enhanced early stage screening platform.

The ambr 15 system was designed to deliver high oxygen transfer rates, rapid pH and feed additions, and is ideally suited for assessing the effects of different strains of microbial cultures. The instrument measures pH and dissolved oxygen every 12 seconds, and computer controlled pumps feed liquid lines for base and nutrient addition to each micro bioreactor.

Each single-use micro bioreactor vessel contains an impeller suitable for fermentation and provides enhanced capability compared to shaking culture systems. Since the ambr 15 vessels are single-use and are supplied sterile, cleaning and sterilization are eliminated, which decreases turnaround times between runs.

Dr. Barney Zoro, ambr product manager at Sartorius Stedim Biotech said, “Scientists have been trying to model microbial fermentation and screen microbial strains using shake plates and flasks but these devices are poor early stage models as they are not able to achieve representative cell densities, and do not allow monitoring and control of pH or dissolved oxygen. With these issues in mind, we developed ambr 15 fermentation and have data showing system consistency, repeatability, and predictive selection of strains. This demonstrates that the system is an excellent tool for enhanced screening applications, and we are confident that fermentation scientists will significantly reduce their time and resource demands when performing enhanced microbial strain selection studies using an ambr 15 fermentation system.”

Related Links:

Sartorius Stedim Biotech



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.